HANALL BIOPHARMA CO.,LTD — Investor Relations & Filings
HanAll Biopharma is a global biopharmaceutical company focused on developing innovative, first-in-class therapies for patients with unmet medical needs. The company's research and development efforts are centered on immunology, ophthalmology, and immuno-oncology, with a specialization in antibody-based therapeutics. Its pipeline includes novel treatments for autoimmune diseases and dry eye disease. The company's mission is to pioneer cutting-edge medicines that address incurable and immune-associated conditions. Alongside its innovative pipeline, HanAll Biopharma also operates a portfolio of pharmaceutical products in therapeutic areas including endocrine, circulatory, and urologic diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| [기재정정]투자판단관련주요경영사항 | 2026-05-20 | Korean | |
| 분기보고서 (2026.03) | 2026-05-15 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-06 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-06 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-06 | Korean | |
| 자기주식처분결과보고서 | 2026-05-06 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46586081 | [기재정정]투자판단관련주요경영사항 | 2026-05-20 | Korean | ||
| 46368702 | 분기보고서 (2026.03) | 2026-05-15 | Korean | ||
| 41760758 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-06 | Korean | ||
| 41760689 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-06 | Korean | ||
| 41760612 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-06 | Korean | ||
| 41760532 | 자기주식처분결과보고서 | 2026-05-06 | Korean | ||
| 41751632 | 최대주주등소유주식변동신고서 | 2026-05-06 | Korean | ||
| 38415211 | 주요사항보고서(자기주식처분결정) | 2026-04-29 | Korean | ||
| 38395701 | 연결재무제표기준영업(잠정)실적(공정공시) | 2026-04-29 | Korean | ||
| 34399037 | 기업설명회(IR)개최(안내공시) | 2026-04-13 | Korean | ||
| 33693322 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-07 | Korean | ||
| 33155574 | 투자판단관련주요경영사항 | 2026-04-02 | Korean | ||
| 33134552 | 주식등의대량보유상황보고서(약식) | 2026-04-01 | Korean | ||
| 33053350 | 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2026-03-27 | Korean | ||
| 33047654 | 정기주주총회결과 | 2026-03-26 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
HANALL BIOPHARMA CO.,LTD via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17133/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17133 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17133 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17133 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17133}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for HANALL BIOPHARMA CO.,LTD (id: 17133)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.